US Broker Ratings

UnitedHealth Group (UNH) Stock Analysis: An Investor’s Perspective on Its 27.92% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a formidable market capitalization of $338.03 billion. As a leader in the healthcare plans industry, UnitedHealth Group offers..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Attractive 24.65% Upside Potential

GE HealthCare Technologies Inc. (GEHC) is establishing itself as a key player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $30.31 billion, this..

AbbVie Inc. (ABBV) Stock Analysis: Exploring Growth Potential with a 5.38% Upside

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, continues to capture the attention of investors with its robust market presence and..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating a 1.53% Potential Upside with Strong Analyst Confidence

Agilent Technologies, Inc. (NYSE: A), a leader in the healthcare sector, particularly in the diagnostics and research industry, is capturing investor attention with its robust market presence and promising growth..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth Potential with a 4.01% Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products and an attractive 4.01% dividend yield. As..

The Cigna Group (CI) Stock Analysis: Potential Upside of 25.67% Amid Strong Buy Ratings

The Cigna Group (NYSE: CI), a venerable name in the healthcare sector, is capturing investor attention with its robust market position and impressive potential upside. Valued at a market cap..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Robust Growth Potential Amidst Biotech Innovations

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the healthcare sector, specifically within biotechnology. With a market capitalization of $133.28 billion, Vertex’s robust portfolio and innovative focus..

Danaher Corporation (DHR) Stock Analysis: Exploring Growth Potential and Analyst Confidence

As a titan in the healthcare sector, Danaher Corporation (NYSE: DHR) continues to capture the attention of investors with its extensive reach in the diagnostics and research industry. With a..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotech Powerhouse with 19.94% Potential Upside

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, continues to hold the investment community’s attention. Headquartered in Basel, Switzerland, BeOne specializes in oncology, developing innovative treatments for..

Veeva Systems Inc. (VEEV) Stock Analysis: Strong Growth in Healthcare Tech Amidst a 5.92% Potential Upside

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based solutions for the life sciences industry, presents an intriguing opportunity for investors within the healthcare sector. With a market capitalization of..

Humana Inc. (HUM) Stock Analysis: Balancing Growth Potential with Market Volatility

Investors eyeing opportunities within the healthcare sector should look closely at Humana Inc. (NYSE: HUM), a major player in the healthcare plans industry. With a substantial market cap of $47.78..

Sanofi (SNY) Stock Analysis: Capitalizing on a 30.68% Potential Upside

Sanofi (NASDAQ: SNY), a heavyweight in the healthcare sector, has long been a pivotal player in the global pharmaceutical landscape. Based in Paris, France, Sanofi is renowned for its diverse..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating a 35% Upside Potential for Investors

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector focusing on the animal health industry, is attracting investor attention with its significant upside potential and robust dividend yield...

Pfizer, Inc. (PFE) Stock Analysis: A Look at Dividend Yield Amidst Market Dynamics

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, has long been a cornerstone for investors seeking exposure to the drug manufacturing industry. With its current market capitalization standing..

Gilead Sciences, Inc. (GILD): Investor Outlook Amid Robust Revenue Growth and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a giant within the healthcare sector, particularly in the drug manufacturing industry. Headquartered in Foster City, California, this biopharmaceutical powerhouse continues to advance..

Novartis AG (NVS) Investor Outlook: Analyzing Growth Potential Amidst a Strong 3.26% Dividend Yield

For investors looking to diversify their portfolios with a robust player in the healthcare sector, Novartis AG (NYSE: NVS) presents an intriguing opportunity. With a market capitalization of $276.48 billion,..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 3.28% Potential Upside Amid Strong Buy Ratings

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, boasting a substantial market capitalization of $367.07 billion. As a significant contributor in the drug..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

Eli Lilly and Company (LLY) Stock Analysis: A Robust 12.28% Upside Potential in the Healthcare Sector

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its promising growth metrics and strategic initiatives. With a market capitalization of..

AngioDynamics, Inc. (ANGO) Investor Outlook: Unpacking the 30.89% Potential Upside

For investors keen on exploring opportunities within the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents a compelling case with a notable potential upside of 30.89%. This medical technology company, headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds